What Is SpO2, Sleep Diagnostic Devices, and Gel Electrophoresis: A Comparison Guide from a Medical Device Quality Manager

When I first started working in medical device quality, I assumed an FDA-cleared device was an FDA-cleared device. Full stop. Clearance meant safe, effective, good enough. Right?

Three years and a lot of verification paperwork later, I learned the hard way that "cleared" doesn't mean "comparable." In our Q1 2024 quality audit, we rejected 12% of first submissions from vendors. Not because anything was dangerous, but because the specs didn't match the real-world use case the devices were being bought for.

I'm a quality compliance manager at Conmed, a medical device manufacturer. I review every product specification and marketing document before it reaches customers—roughly 200 items a year. Whether you're buying a patient monitor, a sleep diagnostic device, or lab equipment like a gel electrophoresis system, I've seen the same pattern repeat: buyers compare the wrong dimensions, then wonder why the device underperforms.

That's why I wrote this guide. I'll set up three comparisons, give you a clear verdict on each, and finish with scenario-based recommendations you can actually use.

The Comparison Framework

When clinical teams ask me for buying advice, the same questions come up over and over:

• What is SpO2, and which monitor actually measures it well?
• Should we invest in an in-lab or home-based sleep diagnostic device?
• Is a traditional gel electrophoresis system still worth buying, or is capillary the only sensible option?

Different products. Same underlying problem. Buyers focus on brand names, screen quality, and price tags—and miss the spec-level details that separate useful devices from expensive shelf decoration.

So here's the roadmap:

• Dimension 1: Pulse oximetry technology (how SpO2 is derived)
• Dimension 2: Sleep diagnostics (in-lab vs. home testing)
• Dimension 3: Gel electrophoresis formats (traditional slab vs. capillary)

Each dimension ends with a verdict. Then I'll wrap up with scenario-based selection advice.

Dimension 1: What Is SpO2, and How Should You Measure It?

Let's start with the basics, because half the buyers I talk to can't answer this precisely.

What is SpO2? It stands for peripheral capillary oxygen saturation. It's an estimate of how much oxygen your hemoglobin is carrying, measured non-invasively through the skin using light absorption. A pulse oximeter shines light through a fingertip, earlobe, or other perfused tissue, measures how much light comes out the other side, and converts that ratio into a percentage.

Sounds simple. It's not.

2-Wavelength vs. Multi-Wavelength Oximetry

The comparison that matters is between traditional 2-wavelength probes and multi-wavelength probes (some use 8 wavelengths or more).

Traditional probes use two wavelengths of light—red and infrared—to distinguish oxygenated from deoxygenated hemoglobin. They work well on healthy patients with good perfusion and no interfering substances. In that population, they're accurate, safe, and inexpensive.

Multi-wavelength probes add more light wavelengths to filter out interference from carboxyhemoglobin, methemoglobin, bilirubin, and even skin pigmentation or motion artifact. This matters more than most buyers realize.

Here's where my initial assumption got corrected. When I first reviewed our monitoring lines, I assumed more wavelengths always meant better performance. Period. Then I looked at the validation data: in healthy adults with normal perfusion, the 2-wavelength device matched the multi-wavelength unit almost exactly. The extra wavelengths mattered in challenging conditions—hypotension, hypothermia, dark skin, carbon monoxide exposure—not in the easy stuff.

So what should you actually compare?

• The validation cohort in the accuracy study
• The A_RMS (root mean square error) reported under ISO 80601-2-61, the international standard for pulse oximeter safety and performance
• Signal processing and motion tolerance
• Which patient populations were included in the clinical trials

ISO 80601-2-61 requires manufacturers to report accuracy against invasive arterial blood gas readings. Lower A_RMS means closer agreement with the invasive gold standard. If a spec sheet doesn't list A_RMS, that's a red flag.

Verdict: For routine ward monitoring on healthy adults, a properly validated 2-wavelength device is often enough. For neonatal, ICU, or ED use—or any population with poor perfusion or suspected carbon monoxide exposure—multi-wavelength technology earns its premium. Don't just ask "what is SpO2?". Ask how the device derives it, and in whom it was validated.

Dimension 2: Sleep Diagnostic Device—In-Lab PSG vs. Home Sleep Apnea Testing

Sleep diagnostics is the category where I see the most buyer confusion. (Not that I blame them—the marketing material is dense.)

The comparison that matters:

In-lab polysomnography (PSG) vs. home sleep apnea testing (HSAT)

In-lab PSG is the traditional gold standard. A patient spends a night in a sleep lab connected to 15–20 channels monitoring brain activity (EEG), eye movement (EOG), muscle tone (EMG), airflow, respiratory effort, oxygen saturation, heart rhythm, and leg movements. It's comprehensive. For complex cases, nothing replaces it.

A home sleep diagnostic device is more limited—usually 3–7 channels. It tracks airflow, respiratory effort, and SpO2, but typically no EEG, so it can't stage sleep. The tradeoff is patient convenience and dramatically lower cost.

Here's the comparison nobody gives you upfront:

Is cost alone enough to choose HSAT? No. And here's the kicker—the thing that surprised me during a sleep clinic's equipment review:

The American Academy of Sleep Medicine (AASM) recommends in-lab PSG for diagnosing narcolepsy, parasomnias, and treatment-resistant sleep apnea. HSAT is reserved for patients with high pre-test probability of moderate-to-severe obstructive sleep apnea and no significant comorbidities.

That's not a soft suggestion. It's a gate. I watched a clinic try to go home-testing-only to cut costs, and within four months, referrals started bouncing back—patients with restless leg syndrome, periodic limb movements, and suspected narcolepsy that HSAT couldn't rule out. (Surprise, surprise.) They lost more revenue in rework and repeat studies than they saved in supplies.

Verdict: Buy sleep diagnostic devices based on your patient population, not your budget alone. A high-acuity sleep center needs in-lab capacity. A high-volume clinic doing routine adult OSA screening can absolutely rely on a good home diagnostic device with reliable SpO2 and airflow sensors. Most successful practices end up with both.

Dimension 3: Gel Electrophoresis—Traditional Slab vs. Capillary Systems

Gel electrophoresis isn't a Conmed product category, but I get questions about it constantly from lab managers browsing our catalog for related equipment. The comparison here:

Traditional slab gel electrophoresis vs. capillary electrophoresis

Traditional slab gel electrophoresis separates DNA, RNA, or proteins by size using an electric field applied across an agarose or polyacrylamide gel matrix. You pour or buy pre-cast gels, load samples into wells by hand, run the current, stain, image, and analyze band patterns. It's hands-on, technique-dependent, and typically takes 1–3 hours per run.

Capillary electrophoresis runs samples through a narrow capillary filled with separation polymer. Samples are injected automatically, separated in 10–30 minutes, and detected by laser-induced fluorescence or UV absorbance as they pass a detection window. No pouring. No staining. No manual imaging.

Here's the head-to-head:

• Resolution: Capillary generally wins, especially for protein separation and DNA fragment analysis.
• Reproducibility: Capillary wins. No hand-poured gels means fewer well-to-well differences.
• Hands-on time: Capillary wins by a mile. Load the sample plate, press start, walk away.
• Throughput: Multi-capillary systems process far more samples per day than a single slab gel rig.
• Flexibility: Traditional slab gels win. Need to excise a band for downstream purification? Slab gels let you do that. Capillary systems generally don't.

Here's what most buyers miss (the outsider blind spot): total cost of ownership. Labs choosing a traditional gel system focus on the low equipment price and forget that every run consumes skilled labor—casting, loading, staining, imaging, documentation. A $3,000 gel box seems like a bargain until your senior tech spends two hours per run babysitting it. Over a year, that labor cost exceeds the instrument cost several times over.

But then again, the research lab across town has the opposite problem. They bought a capillary system for its automation and discovered they couldn't get the flexibility they needed for method development. For them, the slab gel system is the workhorse.

Verdict: For clinical diagnostic labs running standardized, high-volume assays—serum protein electrophoresis, urine protein, hemoglobin variants—capillary is the better long-term investment despite the higher upfront cost. For research labs doing novel method development, band purification, or low-volume specialized work, traditional slab gel electrophoresis is still the right call. The "best" answer depends entirely on your workflow.

Scenario-Based Selection Advice

Bottom line: there's no single "best" device in any of these categories. Here's how I'd decide in your position.

Choose a multi-wavelength patient monitor if:

• Your population includes neonates, patients with dark skin pigmentation, or patients with poor perfusion.
• You deal with motion artifact regularly—anesthesia, ED, post-surgical wards.
• You need reliable SpO2 readings in the presence of CO exposure or abnormal hemoglobin.

Choose a 2-wavelength monitor if:

• You're a low-acuity outpatient clinic, dental surgery center, or primary care practice.
• Your patients are generally healthy with normal perfusion.
• Budget matters and you don't need the advanced filtering.

Choose an in-lab sleep diagnostic device if:

• You're a specialized sleep center receiving complex referrals.
• You suspect narcolepsy, parasomnias, or treatment-resistant apnea.
• You offer CPAP titration as a service.

Choose a home sleep diagnostic device if:

• You're screening for OSA at scale in an otherwise healthy adult population.
• Your patients face transportation or mobility barriers.
• You need to reduce wait times and cost per study.

Choose a capillary electrophoresis system if:

• You run the same standardized assays every day and need reproducibility.
• Your sample volume is high and skilled labor is scarce.
• You need automated data capture and traceability for regulatory compliance.

Choose a traditional gel electrophoresis system if:

• You do research, method development, or band purification.
• Your throughput is low enough that labor cost is a minor factor.
• You need visual inspection of bands as part of the workflow.

Once you've narrowed down your options, log in to your Conmed account (the conmed login portal is at the top of the website) and browse the Conmed product catalog. Every product listing includes the intended use statement, validation summary, and the quality documentation you'll need for your own internal review. I review those documents before they go live. They're the same ones I'd demand as a customer.

Final Thoughts

The thread connecting all three decisions? Don't let a flashy spec sheet do the thinking for you.

When I implemented our verification protocol in 2022, we started requiring every new product to pass a defined clinical-use scenario test before approval. It caught issues before they reached customers. The same principle applies to you: define your patient population, your workflow, and your operator skill level before you compare devices. Write it down. Then ask every vendor—including us—how their product performs in that specific scenario.

An informed customer asks better questions and makes faster decisions. That's good for you. And honestly, it's good for us too. Nobody benefits from a device that sits on a shelf because it didn't fit the workflow.

If you have questions about our patient monitoring products or anything in the catalog, the quality team reads every inquiry that comes through our portal. I'd rather spend ten minutes explaining your options than deal with mismatched expectations later. (As of January 2025, that's the fastest way to reach us.)